Abstract
Vulvodynia is a vulvar discomfort that occurs in the absence of any specific, clinically identifiable disorder. Few therapies have shown to be effective for the treatment of vulvodynia. In our recently published study, we tested a drug-free gel in women affected by vulvar vestibulitis. It is a cosmetic gel which acts locally without any metabolic, pharmacological or immunological effect. In order to further promote the validity of this new product, in this manuscript we analyzed the results obtained from the administration of four questionnaires in the same two groups of women affected by PVD and treated with a placebo and the new product. The questionnaires used: Female Sexual Function Index Scoring (FSFI), Female Sexual Distress Scale (FSDS), Hospital Anxiety and Depression Scale (HADS), and health-related quality of life measured by SF-36 (SF-36). The results obtained by this current analysis showed that the new gel has also proven benefits on women’s quality of life and sexual function, including improvements in arousal, desire, orgasm and satisfaction.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference17 articles.
1. 2015 ISSVD, ISSWSH, and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia;Bornstein;J. Sex. Med.,2016
2. Diagnosis and management of vulvodynia in postmenopausal women;Donders;Maturitas,2018
3. Vulvodynia-Younger Age and Combined Therapies Associate with Significant Reduction in Self-Reported Pain;Aalto;J. Low. Genit. Tract Dis.,2017
4. Sexual Function, Relationship Adjustment, and the Relational Impact of Pain in Male Partners of Women with Provoked Vulvar Pain;Smith;J. Sex. Med.,2014
5. Daily Anxiety and Depressive Symptoms in Couples Coping with Vulvodynia: Associations with Women’s Pain, Women’s Sexual Function, and Both Partners’ Sexual Distress;Rosen;J. Pain,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献